The global Bursitis Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Bursitis is a swelling or inflammation of the bursa – a sac filled with a lubricating fluid and located between the tissues such as bone, skin, tendons and muscles. Lubricating fluid helps in reducing the friction, rubbing and irritation upon movement of a joint. Bursitis affects mainly elbow, hip, shoulder, knee and Achilles tendon. The most common symptoms of bursitis are pain, swelling and stiffness in affected area. Sudden or severe pain may gradually build up, if there is a presence of calcium deposits. Bursitis is commonly caused by the repetitive trauma of injuries on the affected area. Improper posture at home, work and poor stretching before exercise also lead to bursitis. A poorly or an abnormal placed bone or joint can put extra stress on a bursa sac, causing bursitis. Infection from other conditions such as thyroid disorder gout, or unusual medication reactions also increase a person’s risk for bursitis. Sometimes an infection can sometimes lead to inflammation of a bursa. In adults bursitis is very common especially those over 40 years of age. There are number of ways for bursitis treatment like resting the injured area, icing the area, avoiding activities that aggravate the problem, taking over the counter anti-inflammatory medicines and many more. Surgery may be an option when bursitis does not respond to the other treatment options but it is rarely needed.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report includes an overview of the development of the Bursitis Treatment industry chain, the market status of Hospital Pharmacies (Corticosteroids, Antibiotic), Retail Pharmacies (Corticosteroids, Antibiotic), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Bursitis Treatment.
Regionally, the report analyzes the Bursitis Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Bursitis Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Bursitis Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Bursitis Treatment industry.
The report involves analyzing the market at a macro level:
Âé¶¹Ô´´ Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Corticosteroids, Antibiotic).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Bursitis Treatment market.
Regional Analysis: The report involves examining the Bursitis Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Âé¶¹Ô´´ Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Bursitis Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Bursitis Treatment:
Company Analysis: Report covers individual Bursitis Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Bursitis Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Bursitis Treatment. It assesses the current state, advancements, and potential future developments in Bursitis Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Bursitis Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Âé¶¹Ô´´ Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Âé¶¹Ô´´ Segmentation
Bursitis Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Âé¶¹Ô´´ segment by Type
Corticosteroids
Antibiotic
Analgesics
Others
Âé¶¹Ô´´ segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Âé¶¹Ô´´ segment by players, this report covers
Teva Pharmaceutical
Crecent Therapeutics
Arinna Lifesciences Private
Sun Pharmaceutical Industries
Bioanalytical Systems
Perrigo Company
Arbor Pharmaceuticals
Âé¶¹Ô´´ segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bursitis Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bursitis Treatment, with revenue, gross margin and global market share of Bursitis Treatment from 2019 to 2024.
Chapter 3, the Bursitis Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Bursitis Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bursitis Treatment.
Chapter 13, to describe Bursitis Treatment research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Bursitis Treatment
1.2 Âé¶¹Ô´´ Estimation Caveats and Base Year
1.3 Classification of Bursitis Treatment by Type
1.3.1 Overview: Global Bursitis Treatment Âé¶¹Ô´´ Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Bursitis Treatment Consumption Value Âé¶¹Ô´´ Share by Type in 2023
1.3.3 Corticosteroids
1.3.4 Antibiotic
1.3.5 Analgesics
1.3.6 Others
1.4 Global Bursitis Treatment Âé¶¹Ô´´ by Application
1.4.1 Overview: Global Bursitis Treatment Âé¶¹Ô´´ Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.4.5 Drug Stores
1.5 Global Bursitis Treatment Âé¶¹Ô´´ Size & Forecast
1.6 Global Bursitis Treatment Âé¶¹Ô´´ Size and Forecast by Region
1.6.1 Global Bursitis Treatment Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Bursitis Treatment Âé¶¹Ô´´ Size by Region, (2019-2030)
1.6.3 North America Bursitis Treatment Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.4 Europe Bursitis Treatment Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Bursitis Treatment Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.6 South America Bursitis Treatment Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Bursitis Treatment Âé¶¹Ô´´ Size and Prospect (2019-2030)
2 Company Profiles
2.1 Teva Pharmaceutical
2.1.1 Teva Pharmaceutical Details
2.1.2 Teva Pharmaceutical Major Business
2.1.3 Teva Pharmaceutical Bursitis Treatment Product and Solutions
2.1.4 Teva Pharmaceutical Bursitis Treatment Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.1.5 Teva Pharmaceutical Recent Developments and Future Plans
2.2 Crecent Therapeutics
2.2.1 Crecent Therapeutics Details
2.2.2 Crecent Therapeutics Major Business
2.2.3 Crecent Therapeutics Bursitis Treatment Product and Solutions
2.2.4 Crecent Therapeutics Bursitis Treatment Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.2.5 Crecent Therapeutics Recent Developments and Future Plans
2.3 Arinna Lifesciences Private
2.3.1 Arinna Lifesciences Private Details
2.3.2 Arinna Lifesciences Private Major Business
2.3.3 Arinna Lifesciences Private Bursitis Treatment Product and Solutions
2.3.4 Arinna Lifesciences Private Bursitis Treatment Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.3.5 Arinna Lifesciences Private Recent Developments and Future Plans
2.4 Sun Pharmaceutical Industries
2.4.1 Sun Pharmaceutical Industries Details
2.4.2 Sun Pharmaceutical Industries Major Business
2.4.3 Sun Pharmaceutical Industries Bursitis Treatment Product and Solutions
2.4.4 Sun Pharmaceutical Industries Bursitis Treatment Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.4.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
2.5 Bioanalytical Systems
2.5.1 Bioanalytical Systems Details
2.5.2 Bioanalytical Systems Major Business
2.5.3 Bioanalytical Systems Bursitis Treatment Product and Solutions
2.5.4 Bioanalytical Systems Bursitis Treatment Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.5.5 Bioanalytical Systems Recent Developments and Future Plans
2.6 Perrigo Company
2.6.1 Perrigo Company Details
2.6.2 Perrigo Company Major Business
2.6.3 Perrigo Company Bursitis Treatment Product and Solutions
2.6.4 Perrigo Company Bursitis Treatment Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.6.5 Perrigo Company Recent Developments and Future Plans
2.7 Arbor Pharmaceuticals
2.7.1 Arbor Pharmaceuticals Details
2.7.2 Arbor Pharmaceuticals Major Business
2.7.3 Arbor Pharmaceuticals Bursitis Treatment Product and Solutions
2.7.4 Arbor Pharmaceuticals Bursitis Treatment Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.7.5 Arbor Pharmaceuticals Recent Developments and Future Plans
3 Âé¶¹Ô´´ Competition, by Players
3.1 Global Bursitis Treatment Revenue and Share by Players (2019-2024)
3.2 Âé¶¹Ô´´ Share Analysis (2023)
3.2.1 Âé¶¹Ô´´ Share of Bursitis Treatment by Company Revenue
3.2.2 Top 3 Bursitis Treatment Players Âé¶¹Ô´´ Share in 2023
3.2.3 Top 6 Bursitis Treatment Players Âé¶¹Ô´´ Share in 2023
3.3 Bursitis Treatment Âé¶¹Ô´´: Overall Company Footprint Analysis
3.3.1 Bursitis Treatment Âé¶¹Ô´´: Region Footprint
3.3.2 Bursitis Treatment Âé¶¹Ô´´: Company Product Type Footprint
3.3.3 Bursitis Treatment Âé¶¹Ô´´: Company Product Application Footprint
3.4 New Âé¶¹Ô´´ Entrants and Barriers to Âé¶¹Ô´´ Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Âé¶¹Ô´´ Size Segment by Type
4.1 Global Bursitis Treatment Consumption Value and Âé¶¹Ô´´ Share by Type (2019-2024)
4.2 Global Bursitis Treatment Âé¶¹Ô´´ Forecast by Type (2025-2030)
5 Âé¶¹Ô´´ Size Segment by Application
5.1 Global Bursitis Treatment Consumption Value Âé¶¹Ô´´ Share by Application (2019-2024)
5.2 Global Bursitis Treatment Âé¶¹Ô´´ Forecast by Application (2025-2030)
6 North America
6.1 North America Bursitis Treatment Consumption Value by Type (2019-2030)
6.2 North America Bursitis Treatment Consumption Value by Application (2019-2030)
6.3 North America Bursitis Treatment Âé¶¹Ô´´ Size by Country
6.3.1 North America Bursitis Treatment Consumption Value by Country (2019-2030)
6.3.2 United States Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
6.3.3 Canada Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
6.3.4 Mexico Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
7 Europe
7.1 Europe Bursitis Treatment Consumption Value by Type (2019-2030)
7.2 Europe Bursitis Treatment Consumption Value by Application (2019-2030)
7.3 Europe Bursitis Treatment Âé¶¹Ô´´ Size by Country
7.3.1 Europe Bursitis Treatment Consumption Value by Country (2019-2030)
7.3.2 Germany Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.3 France Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.4 United Kingdom Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.5 Russia Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.6 Italy Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Bursitis Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Bursitis Treatment Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Bursitis Treatment Âé¶¹Ô´´ Size by Region
8.3.1 Asia-Pacific Bursitis Treatment Consumption Value by Region (2019-2030)
8.3.2 China Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.3 Japan Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.4 South Korea Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.5 India Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.6 Southeast Asia Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.7 Australia Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
9 South America
9.1 South America Bursitis Treatment Consumption Value by Type (2019-2030)
9.2 South America Bursitis Treatment Consumption Value by Application (2019-2030)
9.3 South America Bursitis Treatment Âé¶¹Ô´´ Size by Country
9.3.1 South America Bursitis Treatment Consumption Value by Country (2019-2030)
9.3.2 Brazil Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
9.3.3 Argentina Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Bursitis Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Bursitis Treatment Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Bursitis Treatment Âé¶¹Ô´´ Size by Country
10.3.1 Middle East & Africa Bursitis Treatment Consumption Value by Country (2019-2030)
10.3.2 Turkey Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
10.3.4 UAE Bursitis Treatment Âé¶¹Ô´´ Size and Forecast (2019-2030)
11 Âé¶¹Ô´´ Dynamics
11.1 Bursitis Treatment Âé¶¹Ô´´ Drivers
11.2 Bursitis Treatment Âé¶¹Ô´´ Restraints
11.3 Bursitis Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Bursitis Treatment Industry Chain
12.2 Bursitis Treatment Upstream Analysis
12.3 Bursitis Treatment Midstream Analysis
12.4 Bursitis Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Teva Pharmaceutical
Crecent Therapeutics
Arinna Lifesciences Private
Sun Pharmaceutical Industries
Bioanalytical Systems
Perrigo Company
Arbor Pharmaceuticals
Ìý
Ìý
*If Applicable.